A detailed history of Pictet Asset Management Sa transactions in Exelixis, Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 1,522,184 shares of EXEL stock, worth $52.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,522,184
Previous 1,037,501 46.72%
Holding current value
$52.4 Million
Previous $20.1 Million 44.45%
% of portfolio
0.03%
Previous 0.03%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$18.17 - $20.48 $8.81 Million - $9.93 Million
484,683 Added 46.72%
1,522,184 $29.1 Million
Q1 2023

May 10, 2023

BUY
$16.3 - $19.41 $10.6 Million - $12.7 Million
652,610 Added 169.56%
1,037,501 $20.1 Million
Q4 2022

Feb 13, 2023

BUY
$14.96 - $17.39 $1.5 Million - $1.74 Million
100,154 Added 35.17%
384,891 $6.17 Million
Q3 2022

Nov 14, 2022

BUY
$15.68 - $22.27 $911,839 - $1.3 Million
58,153 Added 25.67%
284,737 $4.47 Million
Q2 2022

Aug 09, 2022

BUY
$17.44 - $23.16 $559,213 - $742,625
32,065 Added 16.48%
226,584 $4.72 Million
Q1 2022

May 13, 2022

SELL
$17.03 - $22.67 $7.57 Million - $10.1 Million
-444,695 Reduced 69.57%
194,519 $4.41 Million
Q4 2021

Feb 10, 2022

SELL
$15.84 - $21.88 $30.1 Million - $41.6 Million
-1,900,784 Reduced 74.83%
639,214 $11.7 Million
Q3 2021

Nov 12, 2021

BUY
$16.3 - $21.14 $41.4 Million - $53.7 Million
2,539,998 New
2,539,998 $53.7 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.1B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.